Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes. (2022)
Attributed to:
MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41591-022-01790-7
PubMed Identifier: 35534565
Publication URI: http://europepmc.org/abstract/MED/35534565
Type: Journal Article/Review
Volume: 28
Parent Publication: Nature medicine
Issue: 5
ISSN: 1078-8956